On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...

This announcement comes during continued weak performance from Medtronic’s diabetes care division. The company identified a defect relating to battery life and pumps being dropped or hit ...

The company has made both the initial and updated notifications available on the Medtronic Diabetes website. The FDA’s ...

Medtronic has received 11 reports of the issue potentially leading to diabetic ketoacidosis, a life-threatening complication of diabetes that occurs when the body doesn’t have enough insulin.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Medtronic Plc is a medical technology company ... Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment ...

Successfully incorporating AI into future products will fulfil Medtronic’s mission of using biomedical engineering to restore health and reduce the management burden for people with diabetes.

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

His prior experience includes Medtronic’s Diabetes Group, where Le spent over 14 years overseeing financial operations and global expansion with tremendous success, including establishing the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...